Literature DB >> 32603817

Curcumin and LOXblock-1 ameliorate ischemia-reperfusion induced inflammation and acute kidney injury by suppressing the semaphorin-plexin pathway.

Fatih Kar1, Ceyhan Hacioglu2, Hakan Senturk3, Dilek Burukoglu Donmez4, Gungor Kanbak5, Sema Uslu6.   

Abstract

AIMS: Ischemia/reperfusion (I/R) is one of the most important causes of acute kidney injury (AKI), a clinical syndrome with kidney dysfunction and high mortality rates. New diagnostic biomarkers need to be defined to better illuminate the pathophysiology of AKI. For the first time, we aim to investigate the protective effects of Curcumin which is known for its antioxidant and anti-inflammatory properties and 12/15 lipoxygenase inhibitor LOXblock-1 on I/R induced AKI by modulating inflammatory processes, oxidative stress, apoptosis and semaphorin-plexin pathway. MAIN
METHODS: The rats were divided into five groups, with eight animals per group: Sham, I/R, I/R + DMSO (1%, i.p.), I/R + Curcumin (100 mg/kg, i.p.), I/R + LOXblock-1 (2 μg/kg, i.p.). KEY
FINDINGS: The renal function biomarkers (BUN, CREA and UA) in serum were significantly increased in the I/R group. The inflammatory (TNF-α, IL-6 and MCP-1), apoptotic (CYCS and CASP3) and oxidative stress parameters (MDA, MPO, TAS and TOS) measured by ELISA were significantly increased in the I/R group. In histopathological analysis, it was observed that I/R caused serious damage to kidney tissue. SEMA3A was found to increase both serum level and mRNA expression in I/R group. It was observed that curcumin and LOXblock-1 reduce inflammatory processes, oxidative stress and apoptosis via the semaphorin-plexin pathway by both measurements and histopathological analysis. Curcumin was proved more effective than LOXblock-1 with its antioxidant feature in I/R injury. SIGNIFICANCE: The current study reveals the protective effects of Curcumin and LOXblock-1 on acute kidney injury by suppressing SEMA3A as a new biomarker.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AKI; Curcumin; LOXblock-1; Renal I/R; SEMA3A

Mesh:

Substances:

Year:  2020        PMID: 32603817     DOI: 10.1016/j.lfs.2020.118016

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Nanomicellar curcuminoids attenuates renal ischemia/reperfusion injury in rat through prevention of apoptosis and downregulation of MAPKs pathways.

Authors:  Zeinab Karimi; Roksana SoukhakLari; Khojasteh Rahimi-Jaberi; Zahra Esmaili; Maryam Moosavi
Journal:  Mol Biol Rep       Date:  2021-02-19       Impact factor: 2.316

2.  Curcumin ameliorates ischemic stroke injury in rats by protecting the integrity of the blood-brain barrier.

Authors:  Shuguang Wu; Ting Guo; Wenxuan Qi; Yuyu Li; Jie Gu; Cui Liu; Yuehong Sha; Baocheng Yang; Shuqun Hu; Xuemei Zong
Journal:  Exp Ther Med       Date:  2021-05-19       Impact factor: 2.447

Review 3.  Unraveling the Role of 12- and 20- HETE in Cardiac Pathophysiology: G-Protein-Coupled Receptors, Pharmacological Inhibitors, and Transgenic Approaches.

Authors:  Jonathan V Pascale; Pamela A Lucchesi; Victor Garcia
Journal:  J Cardiovasc Pharmacol       Date:  2021-06-01       Impact factor: 3.271

4.  The Therapeutic Effects of Curcumin in Early Septic Acute Kidney Injury: An Experimental Study.

Authors:  Shuo Wang; Ping Zhao; Ying Zhang; Lianhua Zhu; Jianing Zhu; Yukun Luo; Qiuyang Li
Journal:  Drug Des Devel Ther       Date:  2021-10-07       Impact factor: 4.162

5.  A Novel Polysaccharide From Chuanminshen violaceum and Its Protective Effect Against Myocardial Injury.

Authors:  Peng He; Mi Zhang; Meng Zhao; Mengyao Zhang; Benxu Ma; Hongyu Lv; Yantao Han; Dingtao Wu; Zhangfeng Zhong; Wenwen Zhao
Journal:  Front Nutr       Date:  2022-07-14

6.  The Effect of Curcumin on Renal Ischemia/Reperfusion Injury in Diabetic Rats.

Authors:  Douglas Ikedo Machado; Eloiza de Oliveira Silva; Sara Ventura; Maria de Fatima Fernandes Vattimo
Journal:  Nutrients       Date:  2022-07-07       Impact factor: 6.706

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.